pillbase.ru

TIZANIDINE

Active substance: tizanidine

TABLET · TIZANIDINE HYDROCHLORIDE 4 mg/1

United StatesActive

Marketing holder: Aurobindo Pharma Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 25
  • Дорсумио®
    таблетки с пролонгированным высвобождением, 15 мг+6 мг (original in Russian, GRLS)
    ЛП-№(004208)-(РГ-RU)
    Акционерное общество "Валента Фармацевтика" (АО "Валента Фарм")
  • Сирдалуд®
    таблетки, 2 мг (original in Russian, GRLS)
    ЛП-№(009367)-(РГ-RU)
    Сандоз д.д.
  • Сирдалуд®
    таблетки, 2 мг (original in Russian, GRLS)
    П N012947/01
    Сандоз д.д.
  • ТИЗАНИДИН АВЕКСИМА
    таблетки, 2 мг (original in Russian, GRLS)
    ЛП-№(004214)-(РГ-RU)
    Открытое акционерное общество "Авексима"
  • ТИЗАНИДИН АВЕКСИМА
    таблетки, 2 мг (original in Russian, GRLS)
    ЛП-007571
    Открытое акционерное общество "Авексима"
All products in this country (25)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-479e-76bc-aae2-e86150c31b98,01a120c3-5e4a-703f-8fd4-42f0152f5922,01a120c3-6f40-7989-b67f-7e3c2cd11a7f,01a120c3-8de1-7e73-b4da-55859135f2ec,01a120c3-9bfd-7180-a024-c66021ba4651;count=17 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-29e3-798a-a4a6-ecfa3673a840,01a1208c-2ba3-7169-9722-f4e142b35fce,01a1208c-30e6-7d4b-973f-f5c561dcaf27,01a1208c-3475-7795-8fa2-414f0bca3ca2,01a1208c-34a7-7c24-a867-467fd5880128;count=199 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
84386-024
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 84386-024 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 84386-024 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 84386-024 · Verified 2026-10-09 · open in source